Detection of Genetic Markers of Lung Cancer
Recruiting · NCT00280202 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Pittsburgh
View the official record on ClinicalTrials.gov →Interventions studied
Analysis of lymph nodesBiopsy of abnormal & suspicious areas of the bronchial treeBiopsy of the major carinal areaBronchoalveolar Lavage (BAL) for cytokine analysisCorrelation of flow cytometric & RT PCR for TNM stageEvaluation of the tumor for DNA mutations
What this trial is about
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy
- Written informed consent.
- To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass
Exclusion criteria
- None
Where it is running
1 location listed across 1 US state.
- Hillman Cancer Center - Pittsburgh, Pennsylvania, United States